ScinoPharm Taiwan Ltd (1789) — Cash Flow Reinvestment Rate
ScinoPharm Taiwan Ltd (1789) has a Cash Flow Reinvestment Rate of 0.42x as of March 2026, reinvesting NT$83.34 Million (capex NT$83.34 Million ) from operating cash flow of NT$199.47 Million. Check ScinoPharm Taiwan Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ScinoPharm Taiwan Ltd Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for ScinoPharm Taiwan Ltd across 19 annual periods. Explore ScinoPharm Taiwan Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for ScinoPharm Taiwan Ltd (2007–2025)
Year-by-year capital reinvestment analysis for ScinoPharm Taiwan Ltd. For live market cap and broader valuation context, see ScinoPharm Taiwan Ltd market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.42x | NT$1.45 Billion | NT$597.11 Million | NT$291.29 Million | ▲ +529.6% |
| 2024 | 0.38x | NT$288.73 Million | NT$750.91 Million | NT$288.73 Million | ▼ -82.8% |
| 2023 | 2.24x | NT$518.00 Million | NT$231.13 Million | NT$284.71 Million | ▲ +244.3% |
| 2022 | 0.65x | NT$503.66 Million | NT$773.79 Million | NT$250.04 Million | ▼ -43.1% |
| 2021 | 1.14x | NT$582.83 Million | NT$509.82 Million | NT$321.32 Million | ▲ +69.6% |
| 2020 | 0.67x | NT$637.86 Million | NT$946.31 Million | NT$183.10 Million | ▲ +354.8% |
| 2019 | 0.15x | NT$116.94 Million | NT$788.95 Million | NT$105.70 Million | ▼ -39.6% |
| 2018 | 0.25x | NT$302.37 Million | NT$1.23 Billion | NT$127.05 Million | ▼ -45.5% |
| 2017 | 0.45x | NT$437.94 Million | NT$971.71 Million | NT$410.93 Million | ▲ +13.6% |
| 2016 | 0.40x | NT$660.84 Million | NT$1.67 Billion | NT$458.52 Million | ▼ -56.4% |
| 2015 | 0.91x | NT$951.79 Million | NT$1.04 Billion | NT$667.58 Million | ▼ -38.1% |
| 2014 | 1.47x | NT$1.31 Billion | NT$888.29 Million | NT$1.02 Billion | ▲ +2.3% |
| 2013 | 1.44x | NT$1.35 Billion | NT$939.47 Million | NT$1.24 Billion | ▲ +60.3% |
| 2012 | 0.90x | NT$881.19 Million | NT$981.55 Million | NT$881.19 Million | ▲ +43.4% |
| 2011 | 0.63x | NT$810.14 Million | NT$1.29 Billion | NT$810.14 Million | ▲ +141.4% |
| 2010 | 0.26x | NT$405.62 Million | NT$1.56 Billion | NT$405.62 Million | ▲ +75.9% |
| 2009 | 0.15x | NT$191.28 Million | NT$1.30 Billion | NT$191.28 Million | ▲ +43.4% |
| 2008 | 0.10x | NT$144.62 Million | NT$1.41 Billion | NT$144.62 Million | ▼ -37.3% |
| 2007 | 0.16x | NT$82.74 Million | NT$504.50 Million | NT$82.74 Million | — |